Aurora Cannabis (NASDAQ:ACB - Get Free Report) is expected to announce its Q4 2025 earnings results before the market opens on Wednesday, June 18th. Analysts expect Aurora Cannabis to post earnings of $0.11 per share and revenue of $88.85 million for the quarter.
Aurora Cannabis Price Performance
ACB traded up $0.09 during trading hours on Wednesday, hitting $6.04. The company's stock had a trading volume of 1,377,907 shares, compared to its average volume of 1,517,983. The stock has a market cap of $339.53 million, a price-to-earnings ratio of 120.82 and a beta of 1.82. The business's 50-day moving average price is $4.84 and its 200-day moving average price is $4.69. The company has a current ratio of 3.30, a quick ratio of 1.60 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 12 month low of $3.42 and a 12 month high of $7.20.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Aurora Cannabis stock. Jones Financial Companies Lllp lifted its position in Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) by 9,615.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 52,270 shares of the company's stock after purchasing an additional 51,732 shares during the period. Jones Financial Companies Lllp owned 0.09% of Aurora Cannabis worth $229,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 47.63% of the company's stock.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
